Global proteomics experiment using USP9X siRNA (and control) MDA-MB-231 cells with (10 µM, 24 h) and without USP9X inhibitor treatment using WEHI-092 and untreated (DMSO) control (P5448, see sample key). Global proteomics experiment profiling cancer cell lines treated with USP9X inhibitor WEHI-092 (10 µM, 24 h) and untreated (DMSO) control. P4971 1-5 UO-31 cells, untreated P4971 6-10 UO-31 cells, WEHI-092 P4971 11-15 A549 cells, untreated P4971 16-20 A549 cells, WEHI-092 P4971 21-25 DLD-1 cells, untreated P4971 26-30 DLD-1 cells, WEHI-092 P4971 41-45 OVCAR8 cells, untreated P4971 46-50 OVCAR8 cells, WEHI-092 P4971 51-55 SK-MEL-2 cells, untreated P4971 56-60 SK-MEL-2 cells, WEHI-092 P5080 11-15 HMEC-1 cells, untreated P5080 16-20 HMEC-1 cells, WEHI-092